The results obtained here indicate that STAT6-dependent reduction of lethality compromises more than the IgE-mast cell axis, and must be related with a more profound disruption of IL-4-driven Th2 response in the CF mouse but also affecting CF lung disease in humans. The gene discussed is STAT6; the disease is cystic fibrosis.